Zhongli, Taiwan

Zhongli Facility

Our 14,059 square meter Zhongli, Taiwan facility is designed for flexible, high-quality contract liquids, semi-solid and oral solid cGMP drug manufacturing. The facility offers best-in-class capabilities and access to the largest pharmaceutical markets in the world, including North America, European Union and China. 

 
Bora Pharmaceuticals Zhongli Taiwan manufacturing facility exterior with branded entrance signage and production building.

Manufacturing Locations

From our state-of-the-art cGMP manufacturing facilities across North America and Taiwan, Bora supplies drug product to more than 100 countries. Learn more below.
Sterile injectable vials manufactured at a cGMP-compliant pharmaceutical production facility by Bora Pharmaceuticals.

Your Reliable CDMO Partner

As a future-focused CDMO, we know better than most that our own success is shaped by our partners' victories. At Bora Pharmaceuticals, we see it as our mission, our duty, and our responsibility to deliver reliably on time, consistently in full.

You're leaving our site

You are being redirected to BoraBiologics.com